Statements (22)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Sosei_Group_Corporation
|
| gptkbp:acquisitionYear |
2015
|
| gptkbp:collaboratedWith |
gptkb:Pfizer
gptkb:Allergan gptkb:AstraZeneca gptkb:Teva_Pharmaceutical_Industries gptkb:Takeda_Pharmaceutical_Company |
| gptkbp:country |
gptkb:United_Kingdom
|
| gptkbp:focus |
gptkb:G_protein-coupled_receptors_(GPCRs)
|
| gptkbp:foundedYear |
2007
|
| gptkbp:founder |
gptkb:Fiona_Marshall
Malcolm Weir |
| gptkbp:headquartersLocation |
gptkb:Hertfordshire,_United_Kingdom
|
| https://www.w3.org/2000/01/rdf-schema#label |
Heptares Therapeutics
|
| gptkbp:industry |
pharmaceuticals
|
| gptkbp:parentCompany |
gptkb:Sosei_Group_Corporation
|
| gptkbp:productType |
drug discovery
|
| gptkbp:technology |
StaR technology
|
| gptkbp:website |
https://www.heptares.com/
|
| gptkbp:bfsParent |
gptkb:Sosei_Heptares
|
| gptkbp:bfsLayer |
7
|